Results from trial show THC/CBD combination significantly reduces agitation for people with dementia at end of life

A operation of CBD and THC rapidly and importantly reduces agitation successful hospice-eligible radical with dementia, suggest top-line results from the signifier 2 LiBBY (Life's End Benefits of cannaBidiol and tetrahYdrocannabinol) objective trial. The findings were reported for the archetypal clip astatine the Alzheimer's Association International Conference 2026 successful London and online.